The relationship between angiotensin Ⅱ type 1 receptor autoantibody and local inflammation of atherosclerotic plaque
Author:
Affiliation:

1.Department of Cardiovascular Medicine, Zhongshan Hospital, Sun Yat-sen University, Zhongshan, Guangdong 528400, China;2.Department of Hypertension & Vascular Diseases, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China)

Clc Number:

R363

  • Article
  • | |
  • Metrics
  • |
  • Reference [17]
  • | | | |
  • Comments
    Abstract:

    Aim To observe the relationship between the angiotensin Ⅱ Type 1 receptor autoantibody (AT1-AA) and the local inflammation of plaques in atherosclerotic animal model. Methods AT1-AA positive and negative sera were collected and purified from patients with hypertension complicated with acute coronary syndrome. Atherosclerosis models were established in 30 rabbits with hyperlipidemia induced by balloon injury. The animals were randomly divided into 6 groups:(1)control group; (2)low concentration AT1-AA [20 μg/(kg·d)] injection group (LA group); (3)high concentration AT1-AA [40 μg/(kg·d)] injection group (HA group); (4)losartan [20 mg/(kg·d)] lavage+high concentration AT1-AA injection group (L+HA group); (5)simvastatin [4 mg/(kg·d)] lavage+high concentration AT1-AA injection group (S+HA group); (6)7aa [1.5 mg/(kg·d)] lavage+high concentration AT1-AA injection group (7aa+HA group). Each group was treated differently. The abdominal aortas of rabbits were taken out and stained with HE.Image-Pro Express system was used to measure the percentage of atheromatous plaques in the area of lumen. The expressions of MMP-2 in aortic tissue were detected by western blot. Results The values of total cholesterol and low density lipoprotein cholesterol were obviously increased after four weeks. Excluding the control group, the levels of serum AT1-AA in the 8th and 10th week were significantly higher than those at the beginning in the other groups. In LA group and HA group, the relative plaque areas were 46.99%±13.06% and 66.11%±19.67%, respectively, which were significantly higher than those in control group (27.71%±7.46%), L+HA group (34.27%±12.38%), S+HA group (24.03%±8.56%) and 7aa+HA group (28.54%±12.50%) (all P<0.05). The expressions of MMP-2 in LA group and HA group were significantly higher than those in other groups (all P<0.05). Conclusion AT1-AA can accelerate the atheromatous plaque formation in rabbit atherosclerosis model and promote the inflammatory reaction and cells proliferation in local plaque.

    Reference
    [1] GK Hansson.Inflammation, atherosclerosis, and coronary artery disease.N Engl J Med, 5,2(16):1 685-695.
    [2] Stoll G, Bendszus M.Inflammation and atherosclerosis:novel insights into plaque formation and destabilization.Stroke, 6,7(7):1 923-932.
    [3] Libby P, Okamoto Y, Rocha VZ, et al.Inflammation in atherosclerosis:transition from theory to practice.Circ J, 0,4(2):213-220.
    [4] Hansson GK, Hermansson A.The immune system in atherosclerosis.Nat Immunol, 1,2(3):204-212.
    [5] Pueyo ME, Conzalez W, Nicoletti A, et al.Angiotensin II stimulates endothelial vascular cell adhesion molecular-1 via nuclear factor-kappa B activation induced by intracellular oxidative stress.Arterioscler Thromb Vasc Biol, 0,0(3):645-651.
    [6] Nobuhiko A, Suganuma E, Babaev VR, et al.Angiotensin II amplifies macrophage-driven atherosclerosis.Arterioscler Thromb Vasc Biol, 4,4(11):2 143-148.
    [7] Pacurari M, Kafoury R, Tchounwou PB, et al.The renin-angiotensin-aldosterone system in vascular inflammation and remodeling.Int J Inflam, 4,4(3):689 360.
    [8] Wang C, Chang Q, Sun X, et al.Angiotensin II induces an increase in matrix metalloproteinase 2 expression in aortic smooth muscle cells of ascending thoracic aortic aneurysms through JNK, ERK1/2, and p38 MAPK activation.J Cardiovasc Pharmacol, 5,6(3):285-293.
    [9] Yao M, Wang X, Wang X ,et al.The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes.Int J Mol Med, 5,6(1):294-300.
    [10] Newby AC.Metalloproteinases promote plaque rupture and myocardial infarction:A persuasive concept waiting for clinical translation.Matrix Biol, 5,4-46:157-166.
    [11] Shah PK.Biomarkers of plaque instability.Curr Cardiol Rep, 4,6(12):547.
    [12] Sun YX, Zhang HY, Wei YM, et al.The mechanism of signal transduction during vascular smooth muscle cell proliferation induced by autoantibodies against angiotensin AT1 receptor from hypertension.Chin Med J, 8,1(1):43-48.
    [13] Zhu F, Sun YX, Liao YH, et al.Agonistic AT1 receptor autoantibody increases in serum of patients with refractory hypertension and improves Ca2+ mobilization in cultured rat vascular smooth muscle cells.Cell Mol Immunol, 8,5(3):209-217.
    [14] Hansson GK, Libby P, Tabas I.Inflammation and plaque vulnerability.J Intern Med, 5,8(5):483-493.
    [15] Fujimoto S, Hartung D, Ohshima S, et al.Molecular imaging of matrix metalloproteinase in atherosclerotic lesions:Resolution with dietary modification and statin therapy.J Am Coll Cardiol, 8,2 (23):1 847-857.
    [16] Ramadan R, Dhawan SS, Binongo JN.Effect of angiotensin II type I receptor blockade with valsartan on carotid artery atherosclerosis:A double blind randomized clinical trial comparing valsartan and placebo (EFFERVESCENT).Am Heart J, 6,4:68-79.
    [17] Bakris G.Are there effects of renin-angiotensin system antagonists beyond blood pressure control?.Am J Cardiol, 0,5(1 Suppl):21A-29A.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

SUN Yan-Xiang, FENG Li, YUAN Yong, TAO Jun, HUANG Xuan-Sheng, ZHANG Li-Ting. The relationship between angiotensin Ⅱ type 1 receptor autoantibody and local inflammation of atherosclerotic plaque[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(2):134-139.

Copy
Share
Article Metrics
  • Abstract:1114
  • PDF: 986
  • HTML: 0
  • Cited by: 0
History
  • Received:June 29,2016
  • Revised:August 30,2016
  • Online: February 08,2017
Article QR Code